| Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer Y Choi, JW Kim, KH Nam, SH Han, JW Kim, SH Ahn, DJ Park, KW Lee, ... Gastric Cancer 20, 602-611, 2017 | 97 | 2017 |
| Therapeutic implication of HER2 in advanced biliary tract cancer AR Nam, JW Kim, Y Cha, H Ha, JE Park, JH Bang, MH Jin, KH Lee, ... Oncotarget 7 (36), 58007, 2016 | 71 | 2016 |
| A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair–Deficient/Microsatellite Instability–High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer JH Kim, SY Kim, JY Baek, YJ Cha, JB Ahn, HS Kim, KW Lee, JW Kim, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2020 | 69 | 2020 |
| Effect of platinum-based chemotherapy on PD-L1 expression on tumor cells in non-small cell lung cancer J Shin, JH Chung, SH Kim, KS Lee, KJ Suh, JY Lee, JW Kim, JO Lee, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2019 | 69 | 2019 |
| A randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer: KCSG … SY Kim, J Joo, TW Kim, YS Hong, JE Kim, IG Hwang, BG Kim, KW Lee, ... International Journal of Radiation Oncology* Biology* Physics 101 (4), 889-899, 2018 | 60 | 2018 |
| Clinical implications of VEGF, TGF-β1, and IL-1β in patients with advanced non-small cell lung cancer JW Kim, Y Koh, DW Kim, YO Ahn, TM Kim, SW Han, DY Oh, SH Lee, ... Cancer research and treatment: official journal of Korean Cancer Association …, 2013 | 59 | 2013 |
| Epidemiology and management of primary immune thrombocytopenia: a nationwide population-based study in Korea JY Lee, JH Lee, H Lee, B Kang, JW Kim, SH Kim, JO Lee, JW Kim, YJ Kim, ... Thrombosis research 155, 86-91, 2017 | 56 | 2017 |
| EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release KJ Suh, JH Sung, JW Kim, SH Han, HS Lee, A Min, MH Kang, JE Kim, ... Oncotarget 8 (38), 63901, 2017 | 39 | 2017 |
| Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma SM Lim, SH Cho, IG Hwang, JW Choi, H Chang, MJ Ahn, KU Park, ... Cancer research and treatment: official journal of Korean Cancer Association …, 2019 | 38 | 2019 |
| Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation KI Kim, JW Kim, HJ Lee, BS Kim, SM Bang, I Kim, JM Oh, SS Yoon, ... American Journal of Hematology 88 (2), 107-112, 2013 | 36 | 2013 |
| PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer JW Kim, HS Lee, KH Nam, S Ahn, JW Kim, SH Ahn, DJ Park, HH Kim, ... Oncotarget 8 (53), 90948, 2017 | 35 | 2017 |
| Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer JW Kim, DK Kim, A Min, KH Lee, HJ Nam, JH Kim, JS Kim, TY Kim, SA Im, ... Journal of cancer research and clinical oncology 142, 157-165, 2016 | 34 | 2016 |
| Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib-or thalidomide-based chemotherapy JW Kim, CK Min, YC Mun, Y Park, BS Kim, SH Nam, Y Koh, JH Kwon, ... Journal of Clinical Virology 73, 64-69, 2015 | 33 | 2015 |
| A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to … IS Choi, KH Kim, JH Lee, KJ Suh, JW Kim, JH Park, YJ Kim, JS Kim, ... European Journal of Cancer 154, 288-295, 2021 | 32 | 2021 |
| Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years Y Choi, N Kim, CY Yun, YJ Choi, H Yoon, CM Shin, YS Park, SH Ahn, ... Gastric Cancer 23, 1051-1063, 2020 | 31 | 2020 |
| A Phase II Study of Genexol‐PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma B Keam, KW Lee, SH Lee, JS Kim, JH Kim, HG Wu, KY Eom, S Kim, ... The Oncologist 24 (6), 751-e231, 2019 | 31 | 2019 |
| ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy JW Kim, JH Kim, SA Im, YJ Kim, HS Han, JS Kim, SW Han, YK Jeon, ... Oncology 83 (4), 218-227, 2012 | 29 | 2012 |
| PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer KJ Kim, JW Kim, JH Sung, KJ Suh, JY Lee, SH Kim, JO Lee, JW Kim, ... Scientific reports 10 (1), 12308, 2020 | 27 | 2020 |
| Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: a population-based outcomes study IS Choi, M Choi, JH Lee, JH Kim, KJ Suh, JY Lee, B Kang, JW Kim, ... PLoS One 13 (6), e0198544, 2018 | 27 | 2018 |
| Topical recombinant human epidermal growth factor for oral mucositis induced by intensive chemotherapy with hematopoietic stem cell transplantation: Final analysis of a … JW Kim, MG Kim, HJ Lee, Y Koh, JH Kwon, I Kim, S Park, BK Kim, JM Oh, ... PloS one 12 (1), e0168854, 2017 | 26 | 2017 |
